Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration
- Commun Biol. 2022 Dec 7;5(1):1340. doi: 10.1038/s42003-022-04295-8.
- 1. Département de Neurosciences, Université de Montréal, Montréal, QC, Canada.
- 2. Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.
- 3. Centre de Recherche, Institut de Cardiologie de Montréal, Montréal, QC, Canada.
- 4. Département de Biochimie, Université de Montréal, Montréal, QC, Canada.
- 5. Département de Nutrition, Université de Montréal, Montréal, QC, Canada.
- 6. Département de Neurosciences, Université de Montréal, Montréal, QC, Canada. [email protected].
- 7. Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada. [email protected].
The human microbiota is believed to influence health. Microbiome dysbiosis may be linked to neurological conditions like Alzheimer's disease, amyotrophic lateral sclerosis, and Huntington's disease. We report the ability of a probiotic Bacterial strain in halting neurodegeneration phenotypes. We show that Lacticaseibacillus rhamnosus HA-114 is neuroprotective in C. elegans models of amyotrophic lateral sclerosis and Huntington's disease. Our results show that neuroprotection from L. rhamnosus HA-114 is unique from Other L. rhamnosus strains and resides in its fatty acid content. Neuroprotection by L. rhamnosus HA-114 requires acdh-1/ACADSB, kat-1/ACAT1 and elo-6/ELOVL3/6, which are associated with fatty acid metabolism and mitochondrial β-oxidation. Our data suggest that disrupted lipid metabolism contributes to neurodegeneration and that dietary intervention with L. rhamnosus HA-114 restores lipid homeostasis and energy balance through mitochondrial β-oxidation. Our findings encourage the exploration of L. rhamnosus HA-114 derived interventions to modify the progression of neurodegenerative diseases.
-
Cat. No.Product NameDescriptionTargetResearch Area
-